Challenges of Glycemic Control in People With Diabetes and Advanced Kidney Disease and the Potential of Automated Insulin Delivery

Author:

Lu Jean C.123ORCID,Lee Petrova4,Ierino Francesco145,MacIsaac Richard J.123,Ekinci Elif367,O’Neal David123ORCID

Affiliation:

1. Department of Medicine, St Vincent’s Hospital Melbourne, The University of Melbourne, Fitzroy, VIC, Australia

2. Department of Endocrinology and Diabetes, St Vincent’s Hospital Melbourne, Fitzroy, VIC, Australia

3. Australian Centre for Accelerating Diabetes Innovations, The University of Melbourne, Parkville, VIC, Australia

4. Department of Nephrology, St Vincent’s Hospital Melbourne, Fitzroy, VIC, Australia

5. St Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia

6. Department of Endocrinology and Diabetes, Austin Health, Heidelberg, VIC, Australia

7. Department of Medicine, Austin Hospital, The University of Melbourne, Heidelberg, VIC, Australia

Abstract

Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage kidney disease in the world. It is known that maintaining optimal glycemic control can slow the progression of CKD. However, the failing kidney impacts glucose and insulin metabolism and contributes to increased glucose variability. Conventional methods of insulin delivery are not well equipped to adapt to this increased glycemic lability. Automated insulin delivery (AID) has been established as an effective treatment in patients with type 1 diabetes mellitus, and there is emerging evidence for their use in type 2 diabetes mellitus. However, few studies have examined their role in diabetes with concurrent advanced CKD. We discuss the potential benefits and challenges of AID use in patients with diabetes and advanced CKD, including those on dialysis.

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3